Document is current
Any future updates will be listed below
-
Authors
Pillay, Janesh
Flikweert, Antine W.
van Meurs, Matijs
Grootenboers, Marco J.
van der Sar-van der Brugge, Simone
van der Voort, Peter H. J.
Karsdal, Morten A.
Sand, Jannie M. B.
Leeming, Diana J.
Burgess, Janette K.
Moser, Jill
-
Funding
Funding for this research was provided by:
ZonMw (09032212110044, 10430012010006)
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Aspasia 015.013.010)
- License Information
-
More Information
Article History
Received: 10 December 2024
Accepted: 1 January 2025
First Online: 22 January 2025
Declarations
:
: The requirement for informed consent was waived (UMCG METc 2020/492 and Medical Research Ethics Committees United W20.248/Central Research Committee Amphia N2020-0380) as the analyses were performed using residual plasma samples collected for clinical purposes.
: Not applicable.
: This work was supported by ZonMw (project number: 10430012010006), JP is supported by a research grant from the Netherlands Organization for Health Research and Development, The Netherlands (ZonMw Clinical Fellowship grant 09032212110044). JKB was supported by the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) (Aspasia 015.013.010).
: JKB receives unrestricted research funds from Boehringer Ingelheim paid directly to the Institute, unrelated to this work. MAK, DJL and JMBS are full-time employees and stockholders at Nordic Bioscience.
